Alispharm by CBTW is a subsidiary of Collaboration Betters The World (CBTW), a global tech solutions company aiming to exceed industry standards. CBTW operates in over 20 countries with a team of 4,000 experts, offering a wide range of services such as Strategy & Consulting, Innovation & Design, Technology & Engineering, and Industry-Specific solutions. In alignment with its mission, CBTW has committed to allocating 3% of its 2025 revenue to support education projects, emphasizing its dedication to creating a positive impact.
As part of CBTW's larger vision, Alispharm is dedicated to supporting Pharmaceutical, Biotechnology, and Medical Devices Manufacturers in the development of healthcare products, covering areas including Quality Assurance, Qualification/Validation, Regulatory Affairs, Quality Control, and Industrialization. Founded in 2015 and headquartered in France, Alispharm presents a promising investment opportunity in the Health Care and Pharmaceutical industries with its commitment to creating a brighter future for teams, communities, and the planet.